相似文献
1
Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations.人体内去甲替林动力学的遗传控制：对血浆浓度高的先证者亲属的研究
J Med Genet. 1971 Jun;8(2):129-35. doi: 10.1136/jmg.8.2.129.
2
Genetic control of nortriptyline kinetics in man--a study of relatives of propositi with high plasma concentration.人体内去甲替林动力学的遗传控制——对血浆浓度高的先证者亲属的研究
Chem Biol Interact. 1971 Aug;3(4):238-40. doi: 10.1016/0009-2797(71)90041-x.
3
Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.双胞胎中去甲替林的稳态血浆水平：遗传因素和药物治疗的影响。
Br Med J. 1969 Dec 27;4(5686):764-8. doi: 10.1136/bmj.4.5686.764.
4
Kinetics of nortriptyline in man according to a two compartment model.根据二室模型的去甲替林在人体中的药代动力学。
Eur J Clin Pharmacol. 1975 Jun 13;8(5):343-7. doi: 10.1007/BF00562660.
5
Pharmaco-kinetic studies of nortriptyline in man. Influence of genetic and environmental factors.去甲替林在人体中的药代动力学研究。遗传和环境因素的影响。
Acta Pharmacol Toxicol (Copenh). 1970;28(1):11-2.
6
Steady-state plasma nortriptyline concentrations in epileptic patients.癫痫患者的稳态血浆去甲替林浓度。
Br J Clin Pharmacol. 1975 Oct;2(5):469-71. doi: 10.1111/j.1365-2125.1975.tb00559.x.
7
Pharmacokinetic protocol for predicting plasma nortriptyline levels.预测血浆去甲替林水平的药代动力学方案。
J Clin Psychopharmacol. 1983 Dec;3(6):351-6.
8
Correlation between plasma levels of nortriptyline and clinical effects.
Commun Psychopharmacol. 1978;2(5):451-6.
9
Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders.
Pharmakopsychiatr Neuropsychopharmakol. 1976 Jul;9(4):178-82. doi: 10.1055/s-0028-1094492.
10
Plasma prolactin during treatment with nortriptyline.去甲替林治疗期间的血浆催乳素水平。
Neuropsychobiology. 1980;6(1):52-5. doi: 10.1159/000117733.
引用本文的文献
1
Quantitative pharmacogenetics of nortriptyline: a novel approach.去甲替林的定量药物遗传学：一种新方法。
Clin Pharmacokinet. 2001;40(11):869-77. doi: 10.2165/00003088-200140110-00005.
2
Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.去甲替林及其10-羟基代谢物的稳态血浆水平：与CYP2D6基因分型的关系。
Psychopharmacology (Berl). 1996 Feb;123(4):315-9. doi: 10.1007/BF02246640.
3
Defective oxidation of drugs: pharmacokinetic and therapeutic implications.药物氧化缺陷：药代动力学及治疗学意义
Clin Pharmacokinet. 1982 Jan-Feb;7(1):1-22. doi: 10.2165/00003088-198207010-00001.
4
Desipramine pharmacokinetics in Chinese and Caucasian volunteers.地昔帕明在华裔和高加索裔志愿者体内的药代动力学。
Br J Clin Pharmacol. 1984 Apr;17(4):433-40. doi: 10.1111/j.1365-2125.1984.tb02368.x.
5
Assessment of methods to identify sources of interindividual pharmacokinetic variations.个体间药代动力学差异来源识别方法的评估
Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409. doi: 10.2165/00003088-198308050-00002.
6
Antidepressants and barbiturates.抗抑郁药和巴比妥酸盐。
Br Med J. 1971 Oct 9;4(5779):113. doi: 10.1136/bmj.4.5779.113.
7
Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins.
Eur J Clin Pharmacol. 1973 Jun;6(1):44-53. doi: 10.1007/BF00561800.
8
Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.单剂量和多剂量口服后去甲替林在人体内的药代动力学：根据单剂量血浆水平数据预测稳态血浆浓度
Eur J Clin Pharmacol. 1972 Mar;4(2):82-91. doi: 10.1007/BF00562502.
9
Clinical pharmacokinetic considerations in the elderly. An update.老年人的临床药代动力学考量。最新进展。
Clin Pharmacokinet. 1989 Oct;17(4):236-63. doi: 10.2165/00003088-198917040-00003.
10
[Plasma levels of imipramine and desmethylimipramine and antidepressant effect during controlled therapy(author's transl)].
Psychopharmacologia. 1975;41(2):187-95. doi: 10.1007/BF00421078.
本文引用的文献
1
Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.使用丙咪嗪类化合物治疗期间单甲基化三环类抗抑郁药的血浆水平。
Life Sci. 1967 Sep 1;6(17):1895-903. doi: 10.1016/0024-3205(67)90218-4.
2
Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride.同位素衍生技术在仲胺测定中的应用：用H3-乙酸酐乙酰化法测定地昔帕明
J Pharmacol Exp Ther. 1967 Sep;157(3):503-8.
3
Predisposing factors in adverse reactions to drugs.药物不良反应的诱发因素。
Br Med J. 1969 Mar 1;1(5643):536-9. doi: 10.1136/bmj.1.5643.536.
4
Correlation of subjective side effects with plasma concentrations of nortriptyline.主观副作用与去甲替林血浆浓度的相关性。
Br Med J. 1970 Oct 3;4(5726):18-21. doi: 10.1136/bmj.4.5726.18.
5
Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.双胞胎中去甲替林的稳态血浆水平：遗传因素和药物治疗的影响。
Br Med J. 1969 Dec 27;4(5686):764-8. doi: 10.1136/bmj.4.5686.764.
6
Plasma protein binding of tricyclic anti-depressants in man.三环类抗抑郁药在人体中的血浆蛋白结合情况。
Biochem Pharmacol. 1969 Sep;18(9):2135-43. doi: 10.1016/0006-2952(69)90318-9.
Zotero 插件